NAD+observational2014

Formation of [nicotinamide-²H₃]NAD⁺ from [²H₄]nicotinamide and [²H₄]nicotinic acid in human HepG2N cells and involvement of ²H/¹H exchange at the redox site of NAD⁺/NADH.

Journal of nutritional science and vitaminology

confidence

Key findings

Cellular redox reactions convert [Nam-2,4,5,6-D4]NAD+ to [Nam-2,5,6-D3]NAD+; D/H exchange at the redox site explains 1-Da mass decrease.

View source on PubMed (PMID 24759255) ↗

Sample size
Not reported
Population
Human HepG2N cells (in vitro)
Dosing
Stable isotope-labeled precursors [2,4,5,6-D4]nicotinamide and [2,4,5,6-D4]nicotinic acid
Duration
Not reported
Route
In vitro incubation
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

To determine the rates of cellular NAD⁺ synthesis and breakdown, incorporation of stable isotope-labeled precursors into NAD⁺ should be quantified. Although with ²H (D)-labeled precursors [2,4,5,6-D₄]nicotinamide ([D₄]Nam) and [2,4,5,6-D₄]nicotinic acid ([D₄]NA), [D₃]NAD⁺ is formed in human cells, why only three of four D atoms from [D₄]Nam and [D₄]NA are present in NAD⁺ remains unknown. Using a liquid chromatography-tandem mass spectrometry, we tested the involvement of D/¹H (H) exchange at the redox site of NAD⁺/NADH (C-4 carbon of the pyridine ring) by oxidoreductases exhibiting opposite stereospecificity for the coenzymes in the 1-Da mass decrease in the cellular NAD⁺ formation. In all cells examined, [Nam-D₃]NAD⁺, but not [Nam-D₄]NAD⁺, was obtained after the incubation with the D₄-labeled precursors, whereas [Nam-D₄]NAD⁺, but not [Nam-D₃]NAD⁺, was synthesized from the same precursors with purified recombinant NAD⁺ biosynthetic enzymes. [D₄]Nam group of [Nam-D₄]NAD⁺ was converted to [D₃]Nam group via [D₄]NADH by in vitro sequential reduction and oxidation with oxidoreductases exhibiting opposite stereospecificity for the coenzymes. Furthermore, using [2,5,6-D₃]Nam, which has H instead of D at the C-4 carbon, as a precursor of NAD⁺ in the cells, the 1-Da mass decrease in the nucleotide was not observed. Based on these observations, we conclude that following the synthesis of [Nam-2,4,5,6-D₄]NAD⁺, cellular redox reactions of NAD⁺/NADH convert [Nam-2,4,5,6-D₄]NAD⁺ to [Nam-2,5,6-D₃]NAD⁺. Quantification of [Nam-2,5,6-D]NAD⁺ and [2,5,6-D₃]Nam would successfully determine the rate of the NAD⁺ turnover and provide clues to understand regulatory mechanisms of cellular NAD⁺ concentrations.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.